Activation	O
of	O
Stat-3	B-protein
is	O
involved	O
in	O
the	O
induction	O
of	O
apoptosis	O
after	O
ligation	O
of	O
major	B-protein
histocompatibility	I-protein
complex	I-protein
class	I-protein
I	I-protein
molecules	I-protein
on	O
human	B-cell_line
Jurkat	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Activation	O
of	O
Janus	B-protein
tyrosine	I-protein
kinases	I-protein
(	O
Jak	B-protein
)	O
and	O
Signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	O
Stat	B-protein
)	O
after	O
ligation	O
of	O
major	B-protein
histocompatibility	I-protein
complex	I-protein
class	I-protein
I	I-protein
(	O
MHC-I	B-protein
)	O
was	O
explored	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Cross-linking	O
of	O
MHC-I	B-protein
mediated	O
tyrosine	O
phosphorylation	O
of	O
Tyk2	B-protein
,	O
but	O
not	O
Jak1	B-protein
,	O
Jak2	B-protein
,	O
and	O
Jak3	B-protein
.	O

In	O
addition	O
,	O
the	O
transcription	B-protein
factor	I-protein
Stat-3	B-protein
was	O
tyrosine	O
phosphorylated	O
in	O
the	O
cytoplasm	O
and	O
subsequently	O
translocated	O
to	O
the	O
cell	O
nucleus	O
.	O

Data	O
obtained	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
suggested	O
that	O
the	O
activated	B-protein
Stat-3	I-protein
protein	I-protein
associates	O
with	O
the	O
human	B-DNA
serum-inducible	I-DNA
element	I-DNA
(	I-DNA
hSIE	I-DNA
)	I-DNA
DNA-probe	I-DNA
derived	O
from	O
the	O
interferon-gamma	B-DNA
activated	I-DNA
site	I-DNA
(	O
GAS	B-DNA
)	O
in	O
the	O
c-fos	B-DNA
promoter	I-DNA
,	O
a	O
common	O
DNA	O
sequence	O
for	O
Stat	B-protein
protein	I-protein
binding	O
.	O

An	O
association	O
between	O
hSIE	B-DNA
and	O
Stat-3	B-protein
after	O
MHC-I	B-protein
ligation	O
was	O
directly	O
demonstrated	O
by	O
precipitating	O
Stat-3	B-protein
from	O
nuclear	O
extracts	O
with	O
biotinylated	O
hSIE	B-DNA
probe	I-DNA
and	O
avidin	B-protein
-coupled	O
agarose	O
.	O

To	O
investigate	O
the	O
function	O
of	O
the	O
activated	O
Stat-3	B-protein
,	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
were	O
transiently	O
transfected	O
with	O
a	O
Stat-3	B-protein
isoform	I-protein
lacking	O
the	O
transactivating	B-protein
domain	I-protein
.	O

This	O
dominant-negative	B-protein
acting	I-protein
Stat-3	I-protein
isoform	I-protein
significantly	O
inhibited	O
apoptosis	O
induced	O
by	O
ligation	O
of	O
MHC-I	B-protein
.	O

In	O
conclusion	O
,	O
our	O
data	O
suggest	O
the	O
involvement	O
of	O
the	O
Jak/Stat	B-protein
signal	O
pathway	O
in	O
MHC-I	B-protein
-induced	O
signal	O
transduction	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Activation	NULL
of	NULL
Stat-3	NULL
Is	NULL
Involved	NULL
in	NULL
the	NULL
Induction	NULL
of	NULL
Apoptosis	NULL
After	NULL
Ligation	NULL
of	NULL
Major	NULL
Histocompatibility	NULL
Complex	NULL
Class	NULL
I	NULL
Molecules	NULL
on	NULL
Human	NULL
Jurkat	NULL
T	NULL
Cells	NULL
By	NULL
Sgren	NULL
Skov	NULL
,	NULL
Mette	NULL
Nielsen	NULL
,	NULL
Sgren	NULL
Bregenholt	NULL
,	NULL
Niels	NULL
Odum	NULL
,	NULL
and	NULL
Mogens	NULL
H.	NULL
Claesson	NULL
Activation	NULL
of	NULL
Janus	NULL
tyrosine	NULL
kinases	NULL
(	NULL
Jak	NULL
)	NULL
and	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
after	NULL
ligation	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
|	NULL
(	NULL
MHC-	NULL
)	NULL
was	NULL
explored	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cross-linking	NULL
of	NULL
mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
,	NULL
but	NULL
not	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Jak3	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Stat-3	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
cytoplasma	NULL
and	NULL
subsequently	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
.	NULL

Data	NULL
obtained	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
suggested	NULL
that	NULL
the	NULL
activated	NULL
Stat-3	NULL
protein	NULL
associates	NULL
w	NULL
ith	NULL
the	NULL
human	NULL
serum-inducible	NULL
element	NULL
(	NULL
hSIE	NULL
)	NULL
DNA-probe	NULL
derived	NULL
from	NULL
the	NULL
interferon-y	NULL
activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
HE	NULL
MAJOR	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
(	NULL
MHC-I	NULL
)	NULL
complex	NULL
is	NULL
known	NULL
for	NULL
its	NULL
capacity	NULL
to	NULL
present	NULL
peptide	NULL
derived	NULL
from	NULL
intracellular	NULL
proteins	NULL
to	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

!	NULL

Recently	NULL
,	NULL
there	NULL
has	NULL
been	NULL
a	NULL
growing	NULL
interest	NULL
in	NULL
defining	NULL
the	NULL
intracellular	NULL
signals	NULL
and	NULL
their	NULL
consequences	NULL
for	NULL
cell	NULL
activation	NULL
after	NULL
ligation	NULL
of	NULL
MHC-I	NULL
molecules	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
now	NULL
well	NULL
established	NULL
that	NULL
ligation	NULL
of	NULL
MHC-I	NULL
molecules	NULL
expressed	NULL
on	NULL
T	NULL
lymphocytes	NULL
are	NULL
critically	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL
``	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
clarify	NULL
the	NULL
intracellular	NULL
signal	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
that	NULL
operates	NULL
after	NULL
MHC-I	NULL
ligation	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
MHC-I	NULL
cross-linking	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
induces	NULL
tyrosine	NULL
kinase	NULL
and	NULL
PLC-y1	NULL
activity	NULL
.	NULL
``	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
several	NULL
groups	NULL
that	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
TCR/CD3	NULL
molecule	NULL
is	NULL
essential	NULL
for	NULL
MHC-l-induced	NULL
signal	NULL
transduction	NULL
.	NULL
``	NULL

In	NULL
line	NULL
with	NULL
this	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
MHC-I	NULL
molecule	NULL
directly	NULL
uses	NULL
parts	NULL
of	NULL
the	NULL
TCR/CD3	NULL
signal	NULL
transduction	NULL
machinery	NULL
for	NULL
signal	NULL
transduction	NULL
,	NULL
but	NULL
that	NULL
MHC-I	NULL
cross-linking	NULL
leads	NULL
to	NULL
an	NULL
alternative	NULL
TCR/CD3	NULL
{	NULL
-chain	NULL
phosphorylation	NULL
resulting	NULL
in	NULL
an	NULL
altered	NULL
activation	NULL
of	NULL
the	NULL
ZAP7O	NULL
tyrosine	NULL
kinase	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL
``	NULL

Deletion	NULL
of	NULL
all	NULL
but	NULL
the	NULL
four	NULL
proximal	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
MHC-I	NULL
molecule	NULL
does	NULL
not	NULL
alter	NULL
its	NULL
signal	NULL
transduction	NULL
capabili-ties	NULL
,	NULL
``	NULL
?	NULL

strongly	NULL
suggesting	NULL
that	NULL
ligated	NULL
MHC-I	NULL
molecules	NULL
,	NULL
to	NULL
transmit	NULL
a	NULL
signal	NULL
,	NULL
may	NULL
associate	NULL
with	NULL
other	NULL
signal	NULL
transducing	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Medical	NULL
Anatomy	NULL
,	NULL
the	NULL
Panum	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
.	NULL

Submitted	NULL
November	NULL
3	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
February	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Danish	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
the	NULL
Novo	NULL
Nordic	NULL
Foundation	NULL
,	NULL
the	NULL
Beckeit	NULL
Foundation	NULL
,	NULL
the	NULL
Lundbeck	NULL
Foundation	NULL
,	NULL
the	NULL
Leo	NULL
Research	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Alfred	NULL
Benzon	NULL
Foundation	NULL
.	NULL

N.Q	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
the	NULL
Danish	NULL
Allergy	NULL
Research	NULL
Center	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Spren	NULL
Skov	NULL
,	NULL
MSc	NULL
,	NULL
Cell	NULL
Cybernetics	NULL
Laboratory	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
The	NULL
Panum	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
Blegdamsvej	NULL
3	NULL
,	NULL
Bldg	NULL
22-5	NULL
,	NULL
2200	NULL
Copenhagen	NULL
N	NULL
,	NULL
Denmark	NULL
;	NULL
e-mail	NULL
:	NULL
s.skov	NULL
@	NULL
sb.immi.ku.dk	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9110-0047	NULL
$	NULL
3.00/0	NULL
3566	NULL
for	NULL
Stat	NULL
protein	NULL
binding	NULL
.	NULL

An	NULL
association	NULL
between	NULL
hSIE	NULL
and	NULL
Stat-3	NULL
after	NULL
MHC-1	NULL
ligation	NULL
was	NULL
directly	NULL
demonstrated	NULL
by	NULL
precipitating	NULL
Stat-3	NULL
from	NULL
nuclear	NULL
extracts	NULL
with	NULL
biotinylated	NULL
hSIE	NULL
probe	NULL
and	NULL
avidin-coupled	NULL
agarose	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
function	NULL
of	NULL
the	NULL
activated	NULL
Stat-3	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
Stat-3	NULL
isoform	NULL
lacking	NULL
the	NULL
transactivating	NULL
domain	NULL
.	NULL

This	NULL
dominant-negative	NULL
acting	NULL
Stat-3	NULL
isoform	NULL
significantly	NULL
inhibited	NULL
apoptosis	NULL
induced	NULL
by	NULL
ligation	NULL
of	NULL
MHC-I	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Jak/	NULL
Stat	NULL
signal	NULL
pathway	NULL
in	NULL
MHC-l-induced	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Â©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

transmembrane	NULL
molecules	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
MHC-I	NULL
molecules	NULL
can	NULL
associate	NULL
with	NULL
receptores	NULL
for	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
insulin	NULL
and	NULL
glucagon	NULL
receptors	NULL
.	NULL

!	NULL

>	NULL
!	NULL
``	NULL

Ligand	NULL
binding	NULL
of	NULL
many	NULL
different	NULL
cytokine	NULL
receptors	NULL
induces	NULL
Jak	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
and	NULL
Jak	NULL
's	NULL
become	NULL
noncovalently	NULL
associated	NULL
with	NULL
the	NULL
actual	NULL
cytokine	NULL
receptors	NULL
.	NULL

The	NULL
Jak	NULL
kinase	NULL
family	NULL
consists	NULL
of	NULL
Tyk2	NULL
,	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Jak3	NULL
,	NULL
which	NULL
are	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
C-terminal	NULL
kinase-related	NULL
domains	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
SH2	NULL
domains	NULL
.	NULL
``	NULL

The	NULL
Stat	NULL
proteins	NULL
are	NULL
key	NULL
substrates	NULL
for	NULL
the	NULL
Jak	NULL
kinases	NULL
.	NULL

Stat	NULL
proteins	NULL
are	NULL
SH2-containing	NULL
cytoplasmic	NULL
proteins	NULL
,	NULL
which	NULL
associate	NULL
with	NULL
the	NULL
ligand	NULL
activated	NULL
cytokine-receptor/Jak	NULL
kinase	NULL
complex	NULL
via	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
.	NULL
'	NULL

''	NULL
Upon	NULL
tyrosine	NULL
phosphoryla-tion	NULL
,	NULL
Stat	NULL
proteins	NULL
are	NULL
released	NULL
from	NULL
the	NULL
complex	NULL
and	NULL
form	NULL
SH2	NULL
domain	NULL
mediated	NULL
homodimeric	NULL
or	NULL
heterodimeric	NULL
complexes	NULL
.	NULL
'	NULL

''	NULL
``	NULL
These	NULL
complexes	NULL
are	NULL
then	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
regulate	NULL
gene	NULL
transcription	NULL
through	NULL
interaction	NULL
with	NULL
specific	NULL
DNA	NULL
sequences	NULL
,	NULL
most	NULL
of	NULL
which	NULL
are	NULL
related	NULL
to	NULL
the	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
,	NULL
a	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
IFN-y	NULL
inducible	NULL
genes	NULL
.	NULL
``	NULL

Presently	NULL
,	NULL
six	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
family	NULL
are	NULL
identified	NULL
and	NULL
some	NULL
of	NULL
these	NULL
exist	NULL
in	NULL
different	NULL
isoforms	NULL
.	NULL
``	NULL

Each	NULL
Stat	NULL
protein	NULL
functions	NULL
in	NULL
specific	NULL
cytokine-receptor	NULL
signal	NULL
pathways	NULL
.	NULL

Stat-3	NULL
,	NULL
for	NULL
example	NULL
,	NULL
is	NULL
activated	NULL
by	NULL
various	NULL
receptors	NULL
such	NULL
as	NULL
the	NULL
IL-2	NULL
receptor	NULL
,	NULL
``	NULL
``	NULL
IL-3	NULL
receptor	NULL
,	NULL
``	NULL
IL-5	NULL
receptor	NULL
,	NULL
``	NULL
IL-6	NULL
receptor	NULL
,	NULL
``	NULL
``	NULL
IL-9	NULL
receptor	NULL
,	NULL
``	NULL
``	NULL
IL-10	NULL
receptor	NULL
,	NULL
``	NULL
``	NULL
colony-stimulating	NULL
factor-1	NULL
,	NULL
``	NULL
``	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
EGF	NULL
)	NULL
receptor	NULL
,	NULL
``	NULL
``	NULL
>	NULL
``	NULL
and	NULL
the	NULL
thrombopoitin	NULL
receptor	NULL
.	NULL
``	NULL

Evidence	NULL
suggests	NULL
that	NULL
the	NULL
specificity	NULL
of	NULL
Stat	NULL
phosphorylation	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
specificity	NULL
of	NULL
Jak	NULL
activation	NULL
.	NULL

Rather	NULL
,	NULL
it	NULL
is	NULL
hypothesized	NULL
that	NULL
the	NULL
receptor	NULL
complex	NULL
determines	NULL
which	NULL
Stat	NULL
proteins	NULL
will	NULL
be	NULL
accessible	NULL
to	NULL
phosphorylation	NULL
.	NULL
``	NULL

The	NULL
aim	NULL
of	NULL
the	NULL
current	NULL
study	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Jak/Stat	NULL
signal	NULL
pathway	NULL
after	NULL
MHC-I	NULL
ligation	NULL
of	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
(	NULL
Abs	NULL
)	NULL
and	NULL
reagents	NULL
.	NULL

-	NULL
Purified	NULL
antihuman	NULL
B	NULL
;	NULL
microglobu-lin	NULL
(	NULL
anti-B	NULL
;	NULL
m	NULL
)	NULL
Ab	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
DAKO	NULL
A072	NULL
;	NULL
DAKO	NULL
,	NULL
Roskilde	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Purified	NULL
control	NULL
Ig	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
DAKO	NULL
X903	NULL
)	NULL
.	NULL

F101.01	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
,	NULL
which	NULL
recognizes	NULL
a	NULL
conforma-tional	NULL
determinant	NULL
on	NULL
TCR	NULL
``	NULL
was	NULL
used	NULL
as	NULL
an	NULL
ascites	NULL
dilution	NULL
.	NULL

We	NULL
used	NULL
anti-CD3	NULL
(	NULL
UCHT1	NULL
)	NULL
MoAb	NULL
(	NULL
DAKO	NULL
M835	NULL
)	NULL
;	NULL
antiphosphotyrosine	NULL
MoAb	NULL
,	NULL
Blood	NULL
,	NULL
Vol	NULL
91	NULL
,	NULL
No	NULL
10	NULL
(	NULL
May	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
3566-3573	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MHC-MEDIATED	NULL
stat-3	NULL
ACTIVATION	NULL
IN	NULL
APOPTOSIS	NULL
IgG2b	NULL
(	NULL
UBI	NULL
#	NULL
05-321	NULL
)	NULL
;	NULL
purified	NULL
antihuman	NULL
Tyk2	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
UBI	NULL
#	NULL
06-275	NULL
)	NULL
;	NULL
purified	NULL
antihuman	NULL
Jak1	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
UBI	NULL
#	NULL
06-272	NULL
)	NULL
;	NULL
purified	NULL
antihuman	NULL
Jak2	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
UBI	NULL
#	NULL
06-255	NULL
)	NULL
;	NULL
purified	NULL
antihuman	NULL
Jak3	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
UBI	NULL
#	NULL
06-428	NULL
)	NULL
;	NULL
antihuman	NULL
Statl	NULL
,	NULL
MoAb	NULL
,	NULL
IgG2b	NULL
(	NULL
Affinity	NULL
#	NULL
821120	NULL
;	NULL
Mamhead	NULL
,	NULL
Exeter	NULL
,	NULL
UK	NULL
)	NULL
;	NULL
antihuman	NULL
Stat2	NULL
,	NULL
MoAb	NULL
,	NULL
IgG2a	NULL
(	NULL
Affinity	NULL
#	NULL
821220	NULL
)	NULL
;	NULL
antihuman	NULL
Stat-3	NULL
,	NULL
MoAb	NULL
,	NULL
IgG1	NULL
(	NULL
Affinity	NULL
#	NULL
521320	NULL
)	NULL
;	NULL
antihuman	NULL
Stat4	NULL
,	NULL
MoAb	NULL
,	NULL
IgG1	NULL
(	NULL
Affinity	NULL
#	NULL
821420	NULL
)	NULL
;	NULL
antihuman	NULL
Stat5	NULL
,	NULL
MoAb	NULL
,	NULL
IgG2b	NULL
(	NULL
Affinity	NULL
#	NULL
821520	NULL
)	NULL
;	NULL
antihuman	NULL
Stat6	NULL
,	NULL
MoAb	NULL
,	NULL
IgG2b	NULL
(	NULL
Affinity	NULL
#	NULL
825420	NULL
)	NULL
;	NULL
antihuman	NULL
ISGF3Yy	NULL
,	NULL
MoAb	NULL
,	NULL
IgG1	NULL
(	NULL
Affinity	NULL
#	NULL
129320	NULL
)	NULL
;	NULL
peroxidase-conjugated	NULL
antimouse	NULL
Ig	NULL
from	NULL
rabbit	NULL
serum	NULL
(	NULL
DAKO	NULL
P260	NULL
)	NULL
;	NULL
and	NULL
purified	NULL
peroxidase-conjugated	NULL
antirabbit	NULL
Ig	NULL
from	NULL
swine	NULL
serum	NULL
(	NULL
DAKO	NULL
Z196	NULL
)	NULL
.	NULL

Abs	NULL
used	NULL
for	NULL
cell	NULL
exposure	NULL
were	NULL
dialyzed	NULL
against	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
before	NULL
use	NULL
and	NULL
used	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

Abs	NULL
for	NULL
immunoprecipitation	NULL
were	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
description	NULL
.	NULL

Biotin-conjugated	NULL
Abs	NULL
were	NULL
prepared	NULL
by	NULL
reacting	NULL
Ab	NULL
with	NULL
biotinsuccinimide	NULL
(	NULL
Sigma	NULL
B-2643	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Odum	NULL
et	NULL
al	NULL
.	NULL
``	NULL

Avidin	NULL
(	NULL
Sigma	NULL
A9275	NULL
)	NULL
was	NULL
used	NULL
to	NULL
cross-link	NULL
biotin-conjugated	NULL
Ab	NULL
:	NULL
natrium-orthovanadate	NULL
(	NULL
Na	NULL
;	NULL
Sigma	NULL
$	NULL
6508	NULL
)	NULL
;	NULL
protein	NULL
A	NULL
sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
;	NULL
avidin-coupled	NULL
agarose	NULL
(	NULL
Ke-mEnTec	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
)	NULL
;	NULL
Ripa	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris/HCl	NULL
]	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
0.25	NULL
%	NULL
deoxycholate	NULL
wt/vol	NULL
,	NULL
2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
10	NULL
mmol/L	NULL
orthovanadate	NULL
)	NULL
;	NULL
lysis	NULL
buffer	NULL
for	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
purification	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
10	NULL
mmol/L	NULL
orthovanadate	NULL
)	NULL
;	NULL
buffer	NULL
for	NULL
nuclear	NULL
purification	NULL
(	NULL
10	NULL
mmol/L	NULL
KH	NULL
;	NULL
PO,4	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
2.2	NULL
mol/L	NULL
sucrose	NULL
,	NULL
1	NULL
mmol/L	NULL
MgC	NULL
)	NULL
Â»	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
10	NULL
mmol/L	NULL
orthovanadate	NULL
)	NULL
;	NULL
buffer	NULL
for	NULL
cytoplasmic	NULL
purification	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.25	NULL
mol/L	NULL
sucrose	NULL
,	NULL
1	NULL
mmol/L	NULL
MgC	NULL
)	NULL
Â»	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
10	NULL
mmol/L	NULL
orthovanadate	NULL
)	NULL
;	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
lysis	NULL
buffer	NULL
I	NULL
(	NULL
40	NULL
mmol/L	NULL
Tris/HCl	NULL
]	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
2	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
1	NULL
mmol/L	NULL
phenyImethylsufonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
0.1	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO4	NULL
,	NULL
10	NULL
mmol/L	NULL
NaF	NULL
,	NULL
0.1	NULL
mmol/L	NULL
NH	NULL
,	NULL
Molybdate	NULL
,	NULL
10	NULL
umol/L	NULL
Pepstatin	NULL
,	NULL
10	NULL
mmol/L	NULL
B-glycerophosphate	NULL
,	NULL
5	NULL
mmol/L	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
15	NULL
mmol/L	NULL
p-nitrophenylphosphate	NULL
,	NULL
10	NULL
umol/L	NULL
Leupeptin	NULL
)	NULL
;	NULL
and	NULL
EMSA	NULL
lysis	NULL
buffer	NULL
II	NULL
(	NULL
lysis	NULL
buffer	NULL
I	NULL
supplemented	NULL
with	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
300	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1.5	NULL
%	NULL
Ficoll	NULL
)	NULL
.	NULL

All	NULL
buffers	NULL
,	NULL
except	NULL
EMSA	NULL
lysis	NULL
buffers	NULL
,	NULL
were	NULL
supplemented	NULL
with	NULL
a	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
according	NULL
to	NULL
the	NULL
manufactures	NULL
description	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Gmbh	NULL
#	NULL
1697498	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cells	NULL
.	NULL

Jurkat	NULL
cell	NULL
176.25	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
C.	NULL
Geisler	NULL
(	NULL
Institute	NULL
for	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
fresh	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Cells	NULL
were	NULL
continuously	NULL
tested	NULL
to	NULL
be	NULL
mycoplasma	NULL
free	NULL
.	NULL

Cell	NULL
stimulation	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
preincubated	NULL
with	NULL
saturating	NULL
amounts	NULL
of	NULL
biotinylated	NULL
Ab	NULL
or	NULL
biotinylated	NULL
control	NULL
rabbit	NULL
Ig	NULL
(	NULL
both	NULL
1:10	NULL
of	NULL
batch	NULL
concentration	NULL
)	NULL
using	NULL
10	NULL
uL	NULL
antibody/10Â©	NULL
cells	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
uL	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Subsequently	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
(	NULL
37Â°C	NULL
)	NULL
and	NULL
cross-linked	NULL
with	NULL
avidin	NULL
(	NULL
20	NULL
ug/10Â®	NULL
cells	NULL
)	NULL
or	NULL
UCHT-1	NULL
Ab	NULL
(	NULL
2.5	NULL
cells	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
uL	NULL
at	NULL
37Â°C	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

-	NULL
Cells	NULL
(	NULL
3	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
lysed	NULL
in	NULL
1	NULL
mL	NULL
ripa	NULL
buffer	NULL
and	NULL
precleared	NULL
several	NULL
times	NULL
with	NULL
sepharose-coupled	NULL
protein	NULL
A	NULL
(	NULL
50	NULL
%	NULL
wt/vol	NULL
slurry	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
saturating	NULL
amounts	NULL
of	NULL
Ab	NULL
and	NULL
30	NULL
uL	NULL
sepharose-coupled	NULL
protein	NULL
A	NULL
(	NULL
50	NULL
%	NULL
wt/vol	NULL
slurry	NULL
)	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
washed	NULL
,	NULL
subjected	NULL
to	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
polyacrylamide	NULL
electrophoresis	NULL
,	NULL
and	NULL
immunoblotted	NULL
as	NULL
described	NULL
under	NULL
Western	NULL
blots	NULL
.	NULL

Purification	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
cell	NULL
fractions	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
lysed	NULL
in	NULL
2	NULL
mL	NULL
lysis	NULL
buffer	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
nuclear	NULL
and	NULL
the	NULL
cytoplasmic	NULL
cell	NULL
fraction	NULL
were	NULL
prepared	NULL
exactly	NULL
as	NULL
described	NULL
in	NULL
Busch	NULL
.	NULL
``	NULL

3567	NULL
Western	NULL
blots	NULL
.	NULL

Supernatants	NULL
from	NULL
the	NULL
various	NULL
cell	NULL
fractions	NULL
described	NULL
above	NULL
were	NULL
electrophoresed	NULL
on	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
blotted	NULL
on	NULL
to	NULL
a	NULL
Hybond-ECL	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Amersham	NULL
#	NULL
RPN	NULL
2020D	NULL
;	NULL
Amersham	NULL
,	NULL
Allerod	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

The	NULL
immunoblot	NULL
was	NULL
incubated	NULL
with	NULL
primary	NULL
Ab	NULL
according	NULL
to	NULL
the	NULL
manufactures	NULL
instruction	NULL
for	NULL
2	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
1/1,000	NULL
peroxidase-conjugated	NULL
antimouse	NULL
or	NULL
antirabbit	NULL
Ig	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
(	NULL
Amersham	NULL
#	NULL
RPN	NULL
2106	NULL
)	NULL
using	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

EMSA	NULL
analysis	NULL
.	NULL

-	NULL
Cells	NULL
(	NULL
10	NULL
)	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
the	NULL
cell	NULL
membrane	NULL
was	NULL
lysed	NULL
in	NULL
EMSA	NULL
lysis	NULL
buffer	NULL
I	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
nuclear	NULL
fraction	NULL
was	NULL
pelleted	NULL
and	NULL
lysed	NULL
in	NULL
EMSA	NULL
lysis	NULL
buffer	NULL
II	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
in	NULL
the	NULL
lysate	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
bradford	NULL
assay	NULL
.	NULL

The	NULL
M67	NULL
hSIE	NULL
oligo	NULL
(	NULL
5'-TGCAGTCGACATTTCCCGTAAATCGTCGA-3	NULL
'	NULL
,	NULL
3'-CAGCTG-TAAAGGGCATTTAGCAGCTACGT-5	NULL
'	NULL
)	NULL
was	NULL
labeled	NULL
with	NULL
o	NULL
and	NULL
incubated	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
the	NULL
lysate	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4Â°C	NULL
.	NULL

Protein/DNA	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
nondenaturing	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
0.5	NULL
X	NULL
TBE	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
DNA	NULL
(	NULL
50-fold	NULL
excess	NULL
)	NULL
or	NULL
blocking	NULL
Ab	NULL
(	NULL
1	NULL
uL	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
lysate	NULL
15	NULL
minutes	NULL
before	NULL
mixing	NULL
with	NULL
the	NULL
labeled	NULL
M67	NULL
probe	NULL
.	NULL

Alternatively	NULL
,	NULL
proteins	NULL
were	NULL
precipitated	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
(	NULL
EMSA	NULL
lysis	NULL
buffer	NULL
II	NULL
extract	NULL
)	NULL
with	NULL
biotinylated	NULL
M67	NULL
probe	NULL
and	NULL
50	NULL
uL	NULL
avidin-coupled	NULL
agarose	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
subjected	NULL
to	NULL
anti-Stat-3	NULL
Western	NULL
blotting	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Cell	NULL
transfection	NULL
.	NULL

-	NULL
Cells	NULL
(	NULL
3	NULL
X	NULL
10Â°	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
Psg513	NULL
vector	NULL
containing	NULL
the	NULL
sequence	NULL
for	NULL
or	NULL
Stat-3B	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
E.	NULL
Caldenhoven	NULL
and	NULL
are	NULL
described	NULL
in	NULL
detail	NULL
previously	NULL
.	NULL
``	NULL

Transfections	NULL
were	NULL
made	NULL
using	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
and	NULL
10	NULL
uL	NULL
LipofectAMINE	NULL
(	NULL
Life	NULL
Technologia	NULL
,	NULL
Roskilde	NULL
,	NULL
Denmark	NULL
)	NULL
,	NULL
but	NULL
otherwise	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
for	NULL
40	NULL
hours	NULL
and	NULL
subsequently	NULL
assayed	NULL
for	NULL
apoptosis	NULL
and	NULL
Stat-3	NULL
expression	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
measured	NULL
by	NULL
transfecting	NULL
cells	NULL
with	NULL
a	NULL
CD20	NULL
construct	NULL
.	NULL

The	NULL
construct	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
K.	NULL
Helin	NULL
and	NULL
Dr	NULL
E.	NULL
Harlow	NULL
(	NULL
The	NULL
Cancer	NULL
Center	NULL
of	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

CD20	NULL
is	NULL
a	NULL
membrane	NULL
protein	NULL
that	NULL
is	NULL
exclusively	NULL
expressed	NULL
on	NULL
B-cells	NULL
and	NULL
follicular	NULL
dendritic	NULL
cells	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
labeled	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
anti-CD20	NULL
antibody	NULL
(	NULL
DAKO	NULL
;	NULL
F799	NULL
)	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
CD20+*	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Apoptosis	NULL
analysis	NULL
.	NULL

Apoptosis	NULL
was	NULL
in	NULL
principle	NULL
measured	NULL
as	NULL
described	NULL
Cells	NULL
(	NULL
10Â°	NULL
)	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
30	NULL
minutes	NULL
of	NULL
stimulation	NULL
at	NULL
37Â°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
108	NULL
cells/	NULL
mL	NULL
)	NULL
and	NULL
cultured	NULL
for	NULL
6	NULL
hours	NULL
at	NULL
37Â°C	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
2	NULL
mL	NULL
0.03	NULL
%	NULL
saponin	NULL
(	NULL
Sigma	NULL
#	NULL
87900	NULL
)	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
reacted	NULL
with	NULL
1	NULL
mL	NULL
0.4	NULL
ug/mL	NULL
7-aminoactinomycin	NULL
D	NULL
(	NULL
7-AAD	NULL
;	NULL
Sigma	NULL
#	NULL
A9400	NULL
)	NULL
in	NULL
0.03	NULL
%	NULL
saponin	NULL
for	NULL
25	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
immediately	NULL
by	NULL
flow	NULL
cytometry	NULL
in	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
using	NULL
a	NULL
logarithmic	NULL
fluorescence	NULL
scale	NULL
.	NULL

The	NULL
apoptosis	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
sub-G	NULL
staining	NULL
where	NULL
the	NULL
relevant	NULL
background	NULL
staining	NULL
is	NULL
subtracted	NULL
.	NULL

RESULTS	NULL
MHC-I	NULL
ligation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
,	NULL
but	NULL
not	NULL
Jak1-3	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
define	NULL
intracellular	NULL
signal	NULL
transduction	NULL
pathways	NULL
responsible	NULL
for	NULL
alterations	NULL
in	NULL
the	NULL
proliferation	NULL
kinetics	NULL
after	NULL
ligation	NULL
of	NULL
MHC-I	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
,	NULL
which	NULL
recently	NULL
was	NULL
documented	NULL
to	NULL
influence	NULL
cell	NULL
cycle	NULL
kinetics	NULL
.	NULL
``	NULL

Lysates	NULL
from	NULL
MHC	NULL
--	NULL
ligated	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
Abs	NULL
against	NULL
the	NULL
tyrosine	NULL
kinases	NULL
Tyk2	NULL
,	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Jak3	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
different	NULL
kinases	NULL
was	NULL
examined	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
their	NULL
activation	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3568	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Immunoprecipitates	NULL
of	NULL
Tyk2	NULL
obtained	NULL
from	NULL
lysates	NULL
of	NULL
Jurkat	NULL
76.25	NULL
cells	NULL
after	NULL
MHC-1	NULL
or	NULL
TCR/CD3	NULL
ligation	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-B	NULL
;	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
2	NULL
through	NULL
4	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
)	NULL
or	NULL
exposed	NULL
to	NULL
anti-TCR/CD3	NULL
Abs	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
Ab	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Tyk2	NULL
Ab	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
a	NULL
small	NULL
increment	NULL
of	NULL
Tyk2	NULL
phosphorylation	NULL
was	NULL
detected	NULL
after	NULL
2	NULL
minutes	NULL
of	NULL
MHC-I	NULL
cross-linking	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
maximal	NULL
phosphorylation	NULL
was	NULL
seen	NULL
after	NULL
5	NULL
minutes	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TCR/CD3	NULL
cross-linking	NULL
did	NULL
not	NULL
induce	NULL
significant	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Tyk2	NULL
kinase	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
time-dependent	NULL
phosphory-lations	NULL
of	NULL
the	NULL
Tyk2	NULL
kinase	NULL
were	NULL
not	NULL
a	NULL
result	NULL
of	NULL
sequestering	NULL
or	NULL
degradation	NULL
of	NULL
the	NULL
Tyk2	NULL
,	NULL
because	NULL
similar	NULL
amounts	NULL
of	NULL
Tyk2	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lower	NULL
part	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
TCR/	NULL
CD3	NULL
to	NULL
induce	NULL
Tyk2	NULL
phosphorylation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
suboptimal	NULL
TCR/CD3	NULL
stimulation	NULL
,	NULL
because	NULL
both	NULL
MHC-I	NULL
and	NULL
TCR/CD3	NULL
antibodies	NULL
were	NULL
titrated	NULL
and	NULL
used	NULL
at	NULL
saturating	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
is	NULL
higher	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
after	NULL
TCR/CD3	NULL
ligation	NULL
compared	NULL
with	NULL
MHC-I	NULL
ligation	NULL
``	NULL
using	NULL
antibody	NULL
concentrations	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

We	NULL
were	NULL
not	NULL
able	NULL
to	NULL
observe	NULL
any	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
or	NULL
Jak3	NULL
after	NULL
MHC-I	NULL
ligation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MHC-I	NULL
ligation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat-3	NULL
.	NULL

Because	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Tyk2	NULL
kinase	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
MHC-I	NULL
cross-linking	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat1-6	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
immunoprecipitates	NULL
of	NULL
the	NULL
92-kD	NULL
Stat-3	NULL
protein	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
;	NULL
a	NULL
strong	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat-3	NULL
was	NULL
observed	NULL
after	NULL
5	NULL
minutes	NULL
of	NULL
MHC-I	NULL
ligation	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Despite	NULL
a	NULL
pronounced	NULL
effect	NULL
of	NULL
TCR/CD3	NULL
ligation	NULL
on	NULL
the	NULL
overall	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
``	NULL
no	NULL
specific	NULL
phosphorylation	NULL
SKOV	NULL
ET	NULL
AL	NULL
of	NULL
immunopurified	NULL
Stat-3	NULL
was	NULL
observed	NULL
after	NULL
TCR/CD3	NULL
ligation	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
not	NULL
due	NULL
to	NULL
sequestering	NULL
or	NULL
degradation	NULL
of	NULL
the	NULL
Stat-3	NULL
protein	NULL
,	NULL
because	NULL
similar	NULL
amounts	NULL
of	NULL
Stat-3	NULL
were	NULL
immunoprecipitated	NULL
in	NULL
all	NULL
experiments	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lower	NULL
part	NULL
)	NULL
.	NULL

Ligation	NULL
of	NULL
MHC-I	NULL
or	NULL
TCR/CD3	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
,	NULL
Stat2	NULL
,	NULL
Stat4	NULL
,	NULL
Stat5	NULL
,	NULL
or	NULL
Stat6	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MHC-I	NULL
ligation	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
tyrosine-phosphorylated	NULL
Stat-3	NULL
.	NULL

-	NULL
Tyrosine-phosphorylated	NULL
Stat	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
function	NULL
as	NULL
DNA-binding	NULL
transcription	NULL
factors	NULL
.	NULL
``	NULL

To	NULL
determine	NULL
whether	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
after	NULL
MHC-I	NULL
cross-linking	NULL
,	NULL
we	NULL
prepared	NULL
a	NULL
highly	NULL
purified	NULL
nuclear	NULL
fraction	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
an	NULL
antiphosphotyrosine	NULL
immunoblot	NULL
of	NULL
the	NULL
nuclear	NULL
fraction	NULL
after	NULL
MHC-I	NULL
ligation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
fast	NULL
induction	NULL
of	NULL
several	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
in	NULL
whole	NULL
cell	NULL
lysats	NULL
after	NULL
MHC-I	NULL
ligation	NULL
,	NULL
``	NULL
only	NULL
one	NULL
single	NULL
phosphotyrosine	NULL
protein	NULL
at	NULL
92	NULL
kD	NULL
was	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
weakly	NULL
after	NULL
30	NULL
minutes	NULL
of	NULL
MHC-I	NULL
ligation	NULL
and	NULL
more	NULL
pronounced	NULL
after	NULL
60	NULL
minutes	NULL
stimula-tion	NULL
;	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
92-kD	NULL
protein	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
cytoplasma	NULL
and	NULL
then	NULL
subsequently	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
92-kD	NULL
nuclear	NULL
translocated	NULL
protein	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
Stat-3	NULL
protein	NULL
,	NULL
a	NULL
study	NULL
with	NULL
comparable	NULL
kinetics	NULL
,	NULL
as	NULL
described	NULL
above	NULL
,	NULL
was	NULL
performed	NULL
with	NULL
anti-Stat-3	NULL
antibodies	NULL
.	NULL

The	NULL
Stat-3	NULL
protein	NULL
was	NULL
present	NULL
at	NULL
high	NULL
concentrations	NULL
in	NULL
the	NULL
cytoplasma	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
,	NULL
regardless	NULL
of	NULL
cell	NULL
activation	NULL
.	NULL

Ligation	NULL
of	NULL
MHC-I	NULL
molecules	NULL
induced	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

Immunoprecipitates	NULL
of	NULL
Stat-3	NULL
obtained	NULL
from	NULL
lysates	NULL
of	NULL
Jurkat	NULL
76.25	NULL
cells	NULL
after	NULL
MHC-I	NULL
or	NULL
TCR/CD3	NULL
ligation	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-B	NULL
,	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
5	NULL
minutes	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
and/	NULL
or	NULL
exposed	NULL
to	NULL
anti-TCR/	NULL
CD3	NULL
Abs	NULL
for	NULL
5	NULL
minutes	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
Ab	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat-3	NULL
Ab	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MHC-MEDIATED	NULL
stat-3	NULL
ACTIVATION	NULL
IN	NULL
APOPTOSIS	NULL
&	NULL
aS	NULL
$	NULL
$	NULL
Â®	NULL
&	NULL
y	NULL
C	NULL
y	NULL
C	NULL
)	NULL
!	NULL

#	NULL
R	NULL
0	NULL
&	NULL
9	NULL
Â§	NULL
$	NULL
Â§	NULL
$	NULL
~112	NULL
smagntelp	NULL
|	NULL
4	NULL
4	NULL
i|	NULL
784	NULL
``	NULL
35	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Phosphotyrosine	NULL
blot	NULL
of	NULL
the	NULL
nuclear	NULL
fraction	NULL
of	NULL
Jurkat	NULL
76.25	NULL
cells	NULL
after	NULL
MHC-1	NULL
ligation	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-B	NULL
;	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

The	NULL
separated	NULL
proteins	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
Ab	NULL
.	NULL

the	NULL
nuclear	NULL
Stat-3	NULL
concentration	NULL
after	NULL
30	NULL
and	NULL
60	NULL
minutes	NULL
of	NULL
MHC-I	NULL
ligation	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
bands	NULL
under	NULL
Stat-3	NULL
are	NULL
impurities	NULL
of	NULL
the	NULL
nuclear	NULL
fraction	NULL
that	NULL
are	NULL
not	NULL
observed	NULL
consis-tently	NULL
.	NULL

Similar	NULL
studies	NULL
were	NULL
made	NULL
with	NULL
Stat1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
,	NULL
but	NULL
none	NULL
of	NULL
these	NULL
proteins	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
nucleus	NULL
after	NULL
MHC-I	NULL
ligation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

From	NULL
these	NULL
results	NULL
we	NULL
conclude	NULL
that	NULL
MHC-I	NULL
ligation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cytoplasmic	NULL
Stat-3	NULL
that	NULL
subsequently	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
.	NULL

MHC-L-induced	NULL
Stat-3	NULL
binds	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
nuclear	NULL
translocated	NULL
tyrosine-phosphorylated	NULL
Stat-3	NULL
protein	NULL
was	NULL
able	NULL
directly	NULL
to	NULL
associate	NULL
with	NULL
DNA	NULL
,	NULL
an	NULL
EMSA	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
human	NULL
serum-inducible	NULL
element	NULL
(	NULL
hSIE	NULL
)	NULL
probe	NULL
M67	NULL
.	NULL

The	NULL
hSIE	NULL
DNA-probe	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
several	NULL
Stat	NULL
proteins	NULL
,	NULL
including	NULL
Stat-3	NULL
.	NULL
``	NULL

''	NULL
Figure	NULL
5A	NULL
shows	NULL
that	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
30	NULL
minutes	NULL
after	NULL
ligation	NULL
of	NULL
their	NULL
MHC-I	NULL
molecules	NULL
contained	NULL
proteins	NULL
with	NULL
affinity	NULL
for	NULL
the	NULL
hSIE	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
association	NULL
was	NULL
highly	NULL
specific	NULL
,	NULL
because	NULL
the	NULL
association	NULL
with	NULL
the	NULL
labeled	NULL
probe	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ligation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
did	NULL
not	NULL
induce	NULL
shifts	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
hSIE	NULL
probe	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
shifted	NULL
complex	NULL
contained	NULL
the	NULL
Stat-3	NULL
molecule	NULL
,	NULL
an	NULL
inhibition	NULL
experiment	NULL
was	NULL
performed	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
an	NULL
EMSA	NULL
analysis	NULL
in	NULL
which	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
treated	NULL
with	NULL
anti-Stat-3	NULL
or	NULL
isotype	NULL
control	NULL
antibodies	NULL
before	NULL
3569	NULL
incubation	NULL
with	NULL
the	NULL
labeled	NULL
M67	NULL
probe	NULL
.	NULL

No	NULL
supershift	NULL
was	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
but	NULL
the	NULL
shifted	NULL
band	NULL
disappeared	NULL
after	NULL
treatment	NULL
with	NULL
the	NULL
anti-Stat-3	NULL
antibody	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
anti-Stat-3	NULL
antibody	NULL
and	NULL
the	NULL
M67	NULL
probe	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
or	NULL
nearby	NULL
epitopes	NULL
on	NULL
the	NULL
Stat-3	NULL
protein	NULL
.	NULL

To	NULL
show	NULL
that	NULL
Stat-3	NULL
directly	NULL
associates	NULL
with	NULL
hSIE	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
MHC-I	NULL
ligated	NULL
cells	NULL
,	NULL
Stat-3	NULL
was	NULL
precipitated	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
with	NULL
biotinylated	NULL
M67	NULL
probe	NULL
and	NULL
avidin	NULL
coupled	NULL
agarose	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
anti-Stat-3	NULL
antibodies	NULL
.	NULL

Figure	NULL
5C	NULL
shows	NULL
that	NULL
the	NULL
-	NULL
â	NULL
Â°	NULL
&	NULL
Ci	NULL
<	NULL
oÂ°Â§9	NULL
Â®	NULL
$	NULL
4	NULL
m	NULL
y	NULL
C	NULL
C	NULL
Â¢	NULL
F	NULL
F	NULL
Â»	NULL
.	NULL

<	NULL
:	NULL
:	NULL
:	NULL
)	NULL
<	NULL
=	NULL
Stat3	NULL
Fig	NULL
4	NULL
.	NULL

Anti-Stat-3	NULL
immunoblot	NULL
of	NULL
the	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fraction	NULL
of	NULL
Jurkat	NULL
76.25	NULL
cells	NULL
after	NULL
MHC-I	NULL
ligation	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-B	NULL
;	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Cells	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
cytoplasmic	NULL
(	NULL
A	NULL
)	NULL
or	NULL
nuclear	NULL
(	NULL
B	NULL
)	NULL
fraction	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
separated	NULL
fractions	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-Stat-3	NULL
Ab	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3570	NULL
SKOV	NULL
ET	NULL
AL	NULL
ï¬	NULL
<	NULL
wo	NULL
``	NULL
aP	NULL
3	NULL
G	NULL
st	NULL
x8	NULL
F	NULL
$	NULL
_	NULL
$	NULL
&	NULL
-	NULL
yp	NULL
.	NULL

2	NULL
)	NULL
ags	NULL
apn	NULL
Ww	NULL
03	NULL
&	NULL
w	NULL
Â¥	NULL
uC	NULL
xP	NULL
3	NULL
Â«	NULL
&	NULL
$	NULL
9	NULL
)	NULL
,	NULL
$	NULL
9	NULL
,	NULL
yooï¬	NULL
&	NULL
y	NULL
.so	NULL
``	NULL
Blocking	NULL
Ab	NULL
_	NULL
_Stat3	NULL
Control	NULL
Ab	NULL
E	NULL
â¬	NULL
â¬	NULL
&	NULL
on	NULL
Ch	NULL
f=	NULL
Â£	NULL
Â§	NULL
Â®	NULL
3	NULL
G	NULL
o	NULL
B	NULL
o-9	NULL
ps	NULL
o	NULL
A	NULL
:	NULL
g	NULL
'S	NULL
g	NULL
``	NULL
G	NULL
o	NULL
-	NULL
4	NULL
8	NULL
Â£	NULL
ie	NULL
]	NULL
$	NULL
OFS	NULL
Â¢	NULL
P	NULL
$	NULL
4	NULL
$	NULL
oÂ§50Â§5cÂ§	NULL
&	NULL
C	NULL
$	NULL
by	NULL
cP	NULL
w____w	NULL
___w	NULL
*	NULL
mes	NULL
<	NULL
-	NULL
Stat3	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
M67	NULL
hSIE	NULL
DNA	NULL
probe	NULL
after	NULL
MHC-I	NULL
or	NULL
TCR/	NULL
CD3	NULL
ligation	NULL
.	NULL

Cells	NULL
(	NULL
107	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-B	NULL
;	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
3	NULL
through	NULL
5	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
through	NULL
5	NULL
)	NULL
or	NULL
exposed	NULL
to	NULL
anti-TCR/	NULL
CD3	NULL
Ab	NULL
for	NULL
30	NULL
minutes	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
shifted	NULL
DNA	NULL
was	NULL
blocked	NULL
with	NULL
50-fold	NULL
excess	NULL
nonlabeled	NULL
DNA	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
EMSA	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
(	NULL
A	NULL
)	NULL
,	NULL
but	NULL
the	NULL
nuclear	NULL
extract	NULL
w	NULL
as	NULL
preincubated	NULL
for	NULL
15	NULL
minutes	NULL
with	NULL
antibodies	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
M67	NULL
probe	NULL
.	NULL

Experiments	NULL
show	NULL
n	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
were	NULL
preincubated	NULL
with	NULL
anti-Stat-3	NULL
antibody	NULL
and	NULL
those	NULL
show	NULL
n	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
with	NULL
isotype	NULL
control	NULL
antibody	NULL
(	NULL
anti-ISGF-3y	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Precipitation	NULL
of	NULL
Stat-3	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
.	NULL

EMSA	NULL
nuclear	NULL
extract	NULL
was	NULL
made	NULL
as	NULL
described	NULL
under	NULL
(	NULL
A	NULL
)	NULL
and	NULL
precipitated	NULL
with	NULL
a	NULL
biotinylated	NULL
M67	NULL
probe	NULL
and	NULL
avidin-coupled	NULL
agarose	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
PBS	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
saturating	NULL
amounts	NULL
of	NULL
anti-G	NULL
,	NULL
M	NULL
Ab	NULL
(	NULL
lanes	NULL
2	NULL
through	NULL
4	NULL
)	NULL
before	NULL
exposure	NULL
to	NULL
avidin	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
)	NULL
.	NULL

The	NULL
precipitate	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-Stat-3	NULL
Ab	NULL
.	NULL

Stat-3	NULL
protein	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
MHC	NULL
--	NULL
ligated	NULL
cells	NULL
interact	NULL
with	NULL
the	NULL
M67	NULL
probe	NULL
(	NULL
Fig	NULL
5C	NULL
,	NULL
lanes	NULL
2	NULL
through	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
MHC	NULL
--	NULL
induced	NULL
nuclear	NULL
Stat-3	NULL
protein	NULL
can	NULL
associate	NULL
with	NULL
the	NULL
common	NULL
Stat	NULL
binding	NULL
DNA	NULL
sequence	NULL
hSIE	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Overexpression	NULL
of	NULL
Stat-3	NULL
$	NULL
B	NULL
inhibits	NULL
MHC-I-induced	NULL
apoptosis	NULL
.	NULL

-	NULL
To	NULL
assess	NULL
the	NULL
physiological	NULL
function	NULL
of	NULL
Stat-3	NULL
activation	NULL
after	NULL
MHC-I	NULL
ligation	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
normal	NULL
Stat-3	NULL
(	NULL
Stat-3	NULL
Â«	NULL
)	NULL
or	NULL
a	NULL
Stat-3B	NULL
construct	NULL
.	NULL

Stat-3	NULL
$	NULL
B	NULL
is	NULL
an	NULL
isoform	NULL
that	NULL
lacks	NULL
the	NULL
transactivating	NULL
domain	NULL
,	NULL
and	NULL
overexpres-	NULL
sion	NULL
dominantly	NULL
inhibits	NULL
Stat-3-induced	NULL
transcriptional	NULL
activa-tion	NULL
.	NULL

``	NULL
Â®	NULL
Apoptotic	NULL
cells	NULL
have	NULL
condensed	NULL
DNA	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
a	NULL
lower	NULL
stainability	NULL
with	NULL
7-AAD	NULL
.	NULL
``	NULL

Apoptotic	NULL
cells	NULL
are	NULL
therefore	NULL
routinely	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
the	NULL
percentage	NULL
staining	NULL
below	NULL
the	NULL
G	NULL
;	NULL
DNA	NULL
peak	NULL
,	NULL
where	NULL
the	NULL
relevant	NULL
background	NULL
staining	NULL
is	NULL
subtracted	NULL
(	NULL
percentage	NULL
of	NULL
sub-G	NULL
;	NULL
staining	NULL
)	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Fig	NULL
6	NULL
show	NULL
that	NULL
transfection	NULL
with	NULL
Stat-3	NULL
$	NULL
B	NULL
significantly	NULL
inhibits	NULL
MHC-I-induced	NULL
apoptosis	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
Stat-3	NULL
Â«	NULL
or	NULL
a	NULL
control	NULL
CD20	NULL
construct	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Stat-3	NULL
activation	NULL
after	NULL
MHC-I	NULL
ligation	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MHC-MEDIATED	NULL
stat-3	NULL
ACTIVATION	NULL
IN	NULL
APOPTOSIS	NULL
o	NULL
39	NULL
S	NULL
.C	NULL
G	NULL
Â©	NULL
20	NULL
<	NULL
4	NULL
a	NULL
[	NULL
an	NULL
]	NULL
&	NULL
a	NULL
10	NULL
23	NULL
t	NULL
yo	NULL
0	NULL
C-	NULL
]	NULL
Control	NULL
Vector	NULL
transfected	NULL
CD20	NULL
transfected	NULL
BBK	NULL
Stat-30	NULL
.	NULL

transfected	NULL
E	NULL
Stat-3	NULL
$	NULL
B	NULL
transfected	NULL
Fig	NULL
6	NULL
.	NULL

Apoptosis	NULL
measurement	NULL
of	NULL
MHC-I	NULL
ligated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
untransfected	NULL
or	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
,	NULL
CD20	NULL
,	NULL
Stat-3	NULL
Â«	NULL
,	NULL
or	NULL
Stat-38B	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Subsequently	NULL
,	NULL
apoptosis	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
sub-G	NULL
;	NULL
staining	NULL
where	NULL
the	NULL
relevant	NULL
background	NULL
values	NULL
are	NULL
subtracted	NULL
.	NULL

is	NULL
involved	NULL
in	NULL
the	NULL
subsequent	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Because	NULL
Stat-3	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
not	NULL
possible	NULL
to	NULL
measure	NULL
the	NULL
transient	NULL
transfection	NULL
efficiency	NULL
.	NULL

To	NULL
deduce	NULL
the	NULL
transfection	NULL
efficiency	NULL
,	NULL
a	NULL
CD20	NULL
construct	NULL
was	NULL
transiently	NULL
transfected	NULL
in	NULL
parallel	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
using	NULL
the	NULL
same	NULL
transfection	NULL
procedures	NULL
as	NULL
with	NULL
the	NULL
Stat-3	NULL
constructs	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD20+*	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Transfection	NULL
efficiency	NULL
ranged	NULL
from	NULL
35	NULL
%	NULL
to	NULL
45	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MTT	NULL
and	NULL
proliferation	NULL
analyses	NULL
showed	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
viability	NULL
or	NULL
proliferation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
control	NULL
or	NULL
Stat-3	NULL
Â«	NULL
or	NULL
Stat-3B	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
Stat-3	NULL
transfection	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
endogenous	NULL
proliferation	NULL
or	NULL
viability	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
MHC-I-induced	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
may	NULL
lead	NULL
to	NULL
a	NULL
number	NULL
of	NULL
functional	NULL
alterations	NULL
,	NULL
including	NULL
apoptosis	NULL
,	NULL
alteration	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
cytokine	NULL
secretion	NULL
,	NULL
and	NULL
new	NULL
surface	NULL
pheno-types	NULL
.	NULL
``	NULL

To	NULL
further	NULL
clarify	NULL
distinct	NULL
signal	NULL
pathways	NULL
operating	NULL
after	NULL
MHC-I	NULL
ligation	NULL
,	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
Jak/Stat	NULL
signal	NULL
pathway	NULL
in	NULL
MHC	NULL
--	NULL
induced	NULL
signaling	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
was	NULL
investigated	NULL
in	NULL
the	NULL
present	NULL
work	NULL
.	NULL

We	NULL
provide	NULL
here	NULL
evidence	NULL
that	NULL
MHC-I	NULL
ligation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Tyk2	NULL
tyrosine	NULL
kinase	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
none	NULL
of	NULL
the	NULL
other	NULL
Jak	NULL
family	NULL
tyrosine	NULL
kinases	NULL
(	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
or	NULL
Jak3	NULL
)	NULL
was	NULL
activated	NULL
after	NULL
MHC-I	NULL
ligation	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
the	NULL
Stat-family	NULL
proteins	NULL
Stat-1	NULL
through	NULL
Stat-6	NULL
showed	NULL
that	NULL
the	NULL
92-kD	NULL
Stat-3	NULL
protein	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
MHC-I	NULL
ligation	NULL
,	NULL
whereas	NULL
no	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
Stat4	NULL
,	NULL
Stat5	NULL
,	NULL
and	NULL
Stat6	NULL
was	NULL
observed	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
a	NULL
previous	NULL
study	NULL
by	NULL
3571	NULL
Beadling	NULL
et	NULL
al	NULL
,	NULL
``	NULL
Â°	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
activation	NULL
of	NULL
proteins	NULL
from	NULL
the	NULL
Jak	NULL
and	NULL
Stat	NULL
families	NULL
after	NULL
TCR/CD3	NULL
ligation	NULL
.	NULL

Tyrosine-phosphorylated	NULL
Stat	NULL
proteins	NULL
make	NULL
homodimers	NULL
and/or	NULL
heterodimers	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
are	NULL
subsequently	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
by	NULL
a	NULL
currently	NULL
unknown	NULL
mechanism	NULL
.	NULL
``	NULL

To	NULL
elucidate	NULL
whether	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
MHC-I	NULL
ligation	NULL
,	NULL
a	NULL
highly	NULL
purified	NULL
nuclear	NULL
fraction	NULL
was	NULL
obtained	NULL
from	NULL
Jurkat	NULL
T-cell	NULL
lysates	NULL
.	NULL

In	NULL
the	NULL
nuclear	NULL
fraction	NULL
,	NULL
a	NULL
92-kD	NULL
tyrosine-phosphorylated	NULL
protein	NULL
was	NULL
observed	NULL
after	NULL
30	NULL
minutes	NULL
of	NULL
MHC-I	NULL
ligation	NULL
that	NULL
became	NULL
more	NULL
intensively	NULL
phosphorylated	NULL
after	NULL
60	NULL
minutes	NULL
of	NULL
stimulation	NULL
.	NULL

Because	NULL
the	NULL
induction	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
in	NULL
the	NULL
cytolasma	NULL
is	NULL
observed	NULL
within	NULL
5	NULL
seconds	NULL
,	NULL
``	NULL
this	NULL
suggests	NULL
that	NULL
the	NULL
protein	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
cytoplasma	NULL
and	NULL
subsequently	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
.	NULL

Studies	NULL
were	NULL
performed	NULL
to	NULL
elucidate	NULL
whether	NULL
the	NULL
92-kD	NULL
protein	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
Stat-3	NULL
protein	NULL
.	NULL

Immunoblotting	NULL
of	NULL
a	NULL
purified	NULL
nuclear	NULL
lysats	NULL
with	NULL
anti-Stat-3	NULL
antibodies	NULL
showed	NULL
that	NULL
the	NULL
Stat-3	NULL
protein	NULL
was	NULL
indeed	NULL
observed	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
60	NULL
minutes	NULL
of	NULL
MHC-I	NULL
ligation	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
MHC-I	NULL
ligation	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
Stat-3	NULL
transcription	NULL
factor	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
nuclear	NULL
supernatant	NULL
from	NULL
MHC-I-stimulated	NULL
cells	NULL
could	NULL
associate	NULL
with	NULL
the	NULL
hSIE	NULL
DNA	NULL
probe	NULL
derived	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
a	NULL
DNA	NULL
sequence	NULL
known	NULL
to	NULL
associate	NULL
with	NULL
various	NULL
activated	NULL
Stat	NULL
proteins	NULL
,	NULL
including	NULL
Stat-3.5	NULL
``	NULL
In	NULL
a	NULL
gel-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
nuclear	NULL
supernatant	NULL
from	NULL
MHC-Hligated	NULL
Jurkat	NULL
T	NULL
cells	NULL
induced	NULL
a	NULL
clear	NULL
shift	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
hSIE	NULL
probe	NULL
,	NULL
indicating	NULL
an	NULL
association	NULL
between	NULL
the	NULL
hSIE	NULL
DNA	NULL
probe	NULL
and	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
the	NULL
nuclear	NULL
supernatant	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
shifted	NULL
complex	NULL
was	NULL
absent	NULL
in	NULL
nuclear	NULL
extracts	NULL
preincubated	NULL
with	NULL
anti-Stat-3	NULL
antibod-ies	NULL
,	NULL
and	NULL
the	NULL
Stat-3	NULL
protein	NULL
could	NULL
be	NULL
coprecipitated	NULL
from	NULL
nuclear	NULL
cell	NULL
extracts	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
biotinylated	NULL
hSIE	NULL
probe	NULL
and	NULL
avidin-coupled	NULL
agarose	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
Stat-3	NULL
protein	NULL
from	NULL
MHC	NULL
--	NULL
ligated	NULL
cells	NULL
specifically	NULL
interacts	NULL
with	NULL
DNA	NULL
representing	NULL
a	NULL
common	NULL
Stat	NULL
binding	NULL
sequence	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
MHC-I-induced	NULL
Stat-3	NULL
activation	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
constructs	NULL
encoding	NULL
Stat-3	NULL
Â«	NULL
or	NULL
Stat-3B	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
nontransactivating	NULL
isoform	NULL
Stat-3B	NULL
,	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
MHC-I-induced	NULL
apoptosis	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
observed	NULL
.	NULL

Because	NULL
of	NULL
technical	NULL
limitations	NULL
,	NULL
we	NULL
were	NULL
only	NULL
able	NULL
to	NULL
transiently	NULL
transfect	NULL
about	NULL
40	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
;	NULL
therefore	NULL
,	NULL
it	NULL
is	NULL
hard	NULL
to	NULL
judge	NULL
whether	NULL
the	NULL
dominant	NULL
negatively	NULL
acting	NULL
Stat-3B	NULL
totally	NULL
abolish	NULL
apoptosis	NULL
after	NULL
MHC-I	NULL
ligation	NULL
or	NULL
whether	NULL
other	NULL
signals	NULL
participate	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
activated	NULL
Stat-3	NULL
is	NULL
involved	NULL
at	NULL
least	NULL
in	NULL
a	NULL
significant	NULL
part	NULL
of	NULL
the	NULL
intracellular	NULL
signals	NULL
leading	NULL
to	NULL
apoptosis	NULL
after	NULL
MHC-I	NULL
ligation	NULL
.	NULL

We	NULL
tried	NULL
to	NULL
produce	NULL
Jurkat	NULL
T	NULL
cells	NULL
stabily	NULL
transfected	NULL
with	NULL
the	NULL
Stat-3B	NULL
construct	NULL
,	NULL
but	NULL
,	NULL
unfortu-nately	NULL
,	NULL
the	NULL
attempts	NULL
were	NULL
not	NULL
successful	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
found	NULL
that	NULL
JNK	NULL
activity	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
MHC-L-induced	NULL
apoptosis	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
in	NULL
future	NULL
studies	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
elucidate	NULL
the	NULL
cooperation	NULL
between	NULL
JNK	NULL
and	NULL
Stat-3	NULL
in	NULL
MHC-I-induced	NULL
apoptosis	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3572	NULL
It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
MHC-I	NULL
molecule	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
MHC-l-induced	NULL
signal	NULL
transduction	NULL
``	NULL
;	NULL
therefore	NULL
,	NULL
it	NULL
is	NULL
highly	NULL
likely	NULL
that	NULL
the	NULL
MHC-I	NULL
molecule	NULL
associates	NULL
with	NULL
and	NULL
uses	NULL
the	NULL
signal	NULL
transduction	NULL
devices	NULL
of	NULL
other	NULL
transmembrane	NULL
molecules	NULL
.	NULL

The	NULL
MHC-I	NULL
molecules	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
either	NULL
physically	NULL
or	NULL
functionally	NULL
coupled	NULL
to	NULL
other	NULL
signal	NULL
transducing	NULL
proteins	NULL
.	NULL

This	NULL
report	NULL
presents	NULL
evidence	NULL
that	NULL
MHC-I	NULL
ligation	NULL
mediates	NULL
signals	NULL
through	NULL
the	NULL
Jak/Stat	NULL
signal	NULL
pathway	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
tempting	NULL
to	NULL
suggest	NULL
that	NULL
MHC-I	NULL
molecules	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
associate	NULL
with	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
for	NULL
growth	NULL
regulatory	NULL
cytokine	NULL
(	NULL
s	NULL
)	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
MHC-I	NULL
signal	NULL
induces	NULL
secretion	NULL
of	NULL
intracellular	NULL
stores	NULL
of	NULL
cytokines	NULL
to	NULL
the	NULL
media	NULL
,	NULL
which	NULL
then	NULL
mediate	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TYK2	NULL
kinase	NULL
and	NULL
the	NULL
Stat-3	NULL
protein	NULL
through	NULL
their	NULL
respective	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
this	NULL
scenario	NULL
is	NULL
highly	NULL
unlikely	NULL
,	NULL
because	NULL
fresh	NULL
Jurkat	NULL
T	NULL
cells	NULL
exposed	NULL
to	NULL
antibody-depleted	NULL
culture	NULL
supernatants	NULL
from	NULL
2	NULL
to	NULL
10	NULL
minutes	NULL
with	NULL
MHC	NULL
--	NULL
ligated	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
any	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat-3	NULL
(	NULL
data	NULL
not	NULL
included	NULL
)	NULL
.	NULL

The	NULL
MHC	NULL
molecules	NULL
associate	NULL
both	NULL
directly	NULL
and	NULL
functionally	NULL
with	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
receptors'*	NULL
``	NULL
``	NULL
'	NULL
;	NULL
therefore	NULL
,	NULL
these	NULL
receptors	NULL
could	NULL
be	NULL
likely	NULL
candidates	NULL
through	NULL
which	NULL
the	NULL
MHC-I	NULL
molecule	NULL
activates	NULL
TYK2	NULL
and	NULL
Stat-3	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
no	NULL
single	NULL
receptor	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
exclusively	NULL
phosphorylate	NULL
TYK2	NULL
and	NULL
Stat-3	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
MHC-I	NULL
molecules	NULL
do	NULL
not	NULL
uncritically	NULL
use	NULL
cytokine	NULL
receptors	NULL
and	NULL
mediate	NULL
the	NULL
same	NULL
signal	NULL
as	NULL
these	NULL
;	NULL
teleologically	NULL
,	NULL
this	NULL
would	NULL
also	NULL
be	NULL
very	NULL
inappropriate	NULL
in	NULL
a	NULL
complex	NULL
biological	NULL
system	NULL
.	NULL

Rather	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
MHC-I	NULL
molecule	NULL
by	NULL
ligation	NULL
induces	NULL
specific	NULL
changes	NULL
in	NULL
the	NULL
receptor	NULL
to	NULL
which	NULL
it	NULL
associates	NULL
and	NULL
thereby	NULL
induces	NULL
a	NULL
specific	NULL
signal	NULL
.	NULL

The	NULL
precise	NULL
physiological	NULL
function	NULL
of	NULL
Stat	NULL
proteins	NULL
is	NULL
currently	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

One	NULL
or	NULL
more	NULL
Stat	NULL
proteins	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
almost	NULL
all	NULL
known	NULL
cytokines	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
Stat	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
various	NULL
physiological	NULL
signals	NULL
,	NULL
as	NULL
diverse	NULL
as	NULL
signals	NULL
leading	NULL
to	NULL
growth	NULL
progression	NULL
through	NULL
cell	NULL
cycle	NULL
from	NULL
G	NULL
;	NULL
to	NULL
G	NULL
;	NULL
to	NULL
signals	NULL
leading	NULL
to	NULL
growth	NULL
inhibition	NULL
and	NULL
activation-induced	NULL
cell	NULL
death	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
,	NULL
Toshio	NULL
Hirano	NULL
's	NULL
group	NULL
has	NULL
recently	NULL
demonstrated	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
Stat-3	NULL
binding	NULL
domain	NULL
in	NULL
the	NULL
cytoplasmic	NULL
part	NULL
of	NULL
the	NULL
gp130	NULL
chain	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
abolished	NULL
IL-6-induced	NULL
growth	NULL
arrest	NULL
.	NULL
``	NULL

Subsequently	NULL
,	NULL
the	NULL
same	NULL
group	NULL
showed	NULL
that	NULL
dominant-negative	NULL
forms	NULL
of	NULL
Stat-3	NULL
inhibited	NULL
IL-6-induced	NULL
growth	NULL
arrest	NULL
at	NULL
These	NULL
observations	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
observations	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
described	NULL
in	NULL
this	NULL
report	NULL
and	NULL
our	NULL
recent	NULL
data	NULL
showing	NULL
that	NULL
MHC-I	NULL
ligation	NULL
induces	NULL
a	NULL
particular	NULL
anergic-like	NULL
phenotype	NULL
of	NULL
the	NULL
{	NULL
-chain	NULL
and	NULL
ZAP70	NULL
tyrosine	NULL
kinase	NULL
,	NULL
``	NULL
``	NULL
reduces	NULL
colony	NULL
formation	NULL
in	NULL
semisolid	NULL
cul-ture	NULL
,	NULL
``	NULL
*	NULL
and	NULL
is	NULL
a	NULL
key	NULL
inducer	NULL
of	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
.	NULL

46194547	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
staphylococcal	NULL
enterotoxins	NULL
exert	NULL
a	NULL
profound	NULL
inhibitory	NULL
effect	NULL
on	NULL
IL-2-induced	NULL
Jak3	NULL
and	NULL
Stat	NULL
protein	NULL
activation	NULL
,	NULL
``	NULL
a	NULL
process	NULL
dependent	NULL
on	NULL
MHC	NULL
class	NULL
II	NULL
binding	NULL
by	NULL
the	NULL
staphylococcal	NULL
enterotoxin	NULL
(	NULL
N.G	NULL
.	NULL

,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
there	NULL
has	NULL
been	NULL
an	NULL
enormous	NULL
interest	NULL
in	NULL
the	NULL
Jak/Stat	NULL
signal	NULL
pathway	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
its	NULL
biological	NULL
function	NULL
.	NULL

Our	NULL
hypothesis	NULL
is	NULL
that	NULL
the	NULL
MHC-I	NULL
molecule	NULL
uses	NULL
other	NULL
transmembrane	NULL
molecules	NULL
for	NULL
signal	NULL
transduction	NULL
,	NULL
which	NULL
may	NULL
induce	NULL
both	NULL
MHC-I-specific	NULL
signals	NULL
and	NULL
modulation	NULL
SKOV	NULL
ET	NULL
AL	NULL
of	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
this	NULL
signal	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
its	NULL
modulation	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Erik	NULL
Caldenhoven	NULL
(	NULL
University	NULL
Hospital	NULL
Utrecht	NULL
,	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
Stat-3	NULL
constructs	NULL
and	NULL
Tania	NULL
Palm	NULL
and	NULL
Mette	NULL
Jeppesen	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Klein	NULL
J	NULL
:	NULL
Natural	NULL
History	NULL
of	NULL
the	NULL
Major	NULL
Histocompatibility	NULL
Com-plex	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Wiley	NULL
,	NULL
1986	NULL
2	NULL
.	NULL

Tscherning	NULL
T	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
Signal	NULL
transduction	NULL
via	NULL
MHC	NULL
class-I	NULL
molecules	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
39:117	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Takahashi	NULL
H	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Leggatt	NULL
GR	NULL
,	NULL
Ishida	NULL
Y	NULL
,	NULL
Saito	NULL
T	NULL
,	NULL
Yokomuro	NULL
K	NULL
,	NULL
Berzofsky	NULL
JA	NULL
:	NULL
Inactivation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
-1	NULL
envelope-specific	NULL
CD8	NULL
positive	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
by	NULL
free	NULL
antigenic	NULL
peptide	NULL
:	NULL
A	NULL
self-veto	NULL
mechanism	NULL
?	NULL

J	NULL
Exp	NULL
Med	NULL
183:879	NULL
,	NULL
1996	NULL
4	NULL
.	NULL

Sambhara	NULL
SR	NULL
,	NULL
Miller	NULL
RG	NULL
:	NULL
Programmed	NULL
cell	NULL
death	NULL
of	NULL
T	NULL
cells	NULL
signaled	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
and	NULL
the	NULL
alpha	NULL
3	NULL
domain	NULL
of	NULL
class	NULL
I	NULL
MHC	NULL
.	NULL

Science	NULL
252:1424	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Bregenholt	NULL
S	NULL
,	NULL
Ripke	NULL
M	NULL
,	NULL
Skov	NULL
S	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
Ligation	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
induces	NULL
new	NULL
phenotypes	NULL
and	NULL
functions	NULL
.	NULL

J	NULL
Immunol	NULL
157:993	NULL
,	NULL
1996	NULL
6	NULL
.	NULL

Skov	NULL
S	NULL
,	NULL
Klausen	NULL
P	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
Ligation	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
human	NULL
T-cells	NULL
induces	NULL
cell	NULL
death	NULL
through	NULL
PI-3	NULL
kinase-induced	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
activity	NULL
:	NULL
A	NULL
novel	NULL
pathway	NULL
distinct	NULL
from	NULL
Fas-induced	NULL
apoptosis	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
139:1523	NULL
,	NULL
1997	NULL
7	NULL
.	NULL

Skov	NULL
S	NULL
,	NULL
Odum	NULL
N	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
MHC-class	NULL
I	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
and	NULL
PLC	NULL
gammal	NULL
phosphorylation	NULL
.	NULL

J	NULL
Immunol	NULL
154:1167	NULL
,	NULL
1995	NULL
8	NULL
.	NULL

Dissing	NULL
S	NULL
,	NULL
Geisler	NULL
C	NULL
,	NULL
Rubin	NULL
B	NULL
,	NULL
Plesner	NULL
T	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

II	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
T	NULL
lymphoma	NULL
cells	NULL
by	NULL
cross-linking	NULL
of	NULL
their	NULL
MHC	NULL
class	NULL
I	NULL
antigens	NULL
.	NULL

Cell	NULL
Immunol	NULL
126:196	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Geppert	NULL
TD	NULL
,	NULL
Wacholtz	NULL
MC	NULL
,	NULL
Patel	NULL
SS	NULL
,	NULL
Lightfoot	NULL
E	NULL
,	NULL
Lipsky	NULL
PE	NULL
:	NULL
Activation	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
Jurkat	NULL
cells	NULL
by	NULL
cross-linking	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
.	NULL

J	NULL
Immunol	NULL
142:3763	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Skov	NULL
S	NULL
,	NULL
Bregenholt	NULL
S	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
MHC	NULL
class	NULL
I	NULL
ligation	NULL
of	NULL
human	NULL
T-cells	NULL
activates	NULL
the	NULL
ZAP70	NULL
and	NULL
the	NULL
P561ck	NULL
tyrosine	NULL
kinases	NULL
,	NULL
leads	NULL
to	NULL
an	NULL
alternative	NULL
phenotype	NULL
of	NULL
the	NULL
TCR/CD3	NULL
zeta-chain	NULL
,	NULL
and	NULL
induces	NULL
apoptosis	NULL
.	NULL

J	NULL
Immunol	NULL
158:3189	NULL
,	NULL
1997	NULL
11	NULL
.	NULL

Gur	NULL
H	NULL
,	NULL
el-Zaatari	NULL
F	NULL
,	NULL
Geppert	NULL
TD	NULL
,	NULL
Wacholtz	NULL
MC	NULL
,	NULL
Taurog	NULL
JD	NULL
,	NULL
Lipsky	NULL
PE	NULL
:	NULL
Analysis	NULL
of	NULL
T	NULL
cell	NULL
signaling	NULL
by	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
:	NULL
The	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
not	NULL
required	NULL
for	NULL
signal	NULL
transduction	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:1267	NULL
,	NULL
1990	NULL
12	NULL
.	NULL

Gur	NULL
H	NULL
,	NULL
Geppert	NULL
TD	NULL
,	NULL
Lipsky	NULL
PE	NULL
:	NULL
The	NULL
cytoplasmatic	NULL
domain	NULL
is	NULL
not	NULL
required	NULL
for	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
to	NULL
aggregate	NULL
,	NULL
internalize	NULL
,	NULL
and	NULL
stimulate	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

FASEB	NULL
J	NULL
5	NULL
:	NULL
A990	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Due	NULL
C	NULL
,	NULL
Simonsen	NULL
M	NULL
,	NULL
Olsson	NULL
L	NULL
:	NULL
The	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
heavy	NULL
chain	NULL
as	NULL
a	NULL
structural	NULL
subunit	NULL
of	NULL
the	NULL
human	NULL
cell	NULL
membrane	NULL
insulin	NULL
receptor	NULL
:	NULL
Implications	NULL
for	NULL
the	NULL
range	NULL
of	NULL
biological	NULL
functions	NULL
of	NULL
histocompatibility	NULL
antigens	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:6007	NULL
,	NULL
1986	NULL
14	NULL
.	NULL

Centrella	NULL
M	NULL
,	NULL
McCarthy	NULL
TL	NULL
,	NULL
Canalis	NULL
E	NULL
:	NULL
Beta	NULL
2-microglobulin	NULL
enhances	NULL
insulin-like	NULL
growth	NULL
factor	NULL
I	NULL
receptor	NULL
levels	NULL
and	NULL
synthesis	NULL
in	NULL
bone	NULL
cell	NULL
cultures	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:18268	NULL
,	NULL
1989	NULL
15	NULL
.	NULL

Schreiber	NULL
AB	NULL
,	NULL
Schlessinger	NULL
J	NULL
,	NULL
Edidin	NULL
M	NULL
:	NULL
Interaction	NULL
between	NULL
major	NULL
histocompatibility	NULL
complex	NULL
antigens	NULL
and	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptors	NULL
on	NULL
human	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
98:725	NULL
,	NULL
1984	NULL
16	NULL
.	NULL

Sharon	NULL
M	NULL
,	NULL
Gnarra	NULL
JR	NULL
,	NULL
Baniyash	NULL
M	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
Possible	NULL
association	NULL
between	NULL
IL-2	NULL
receptors	NULL
and	NULL
class	NULL
I	NULL
HLA	NULL
molecules	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
141:3512	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Hansen	NULL
NQ	NULL
,	NULL
Tscherning	NULL
T	NULL
,	NULL
Claesson	NULL
MH	NULL
:	NULL
T-cell	NULL
activation	NULL
.	NULL

IV	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MHC-MEDIATED	NULL
stat-3	NULL
ACTIVATION	NULL
IN	NULL
APOPTOSIS	NULL
Evidence	NULL
for	NULL
a	NULL
functional	NULL
linkage	NULL
between	NULL
MHC	NULL
class	NULL
I	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
,	NULL
and	NULL
interleukin-4	NULL
receptor	NULL
molecules	NULL
.	NULL

Cytokine	NULL
3:35	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Firmbach-Kraft	NULL
I	NULL
,	NULL
Byers	NULL
M	NULL
,	NULL
Shows	NULL
T	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Krolewski	NULL
JJ	NULL
:	NULL
tyk2	NULL
,	NULL
prototype	NULL
of	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
non-receptor	NULL
tyrosine	NULL
kinase	NULL
genes	NULL
.	NULL

Oncogene	NULL
5:1329	NULL
,	NULL
1990	NULL
19	NULL
.	NULL

Thie	NULL
JN	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Silvennoinen	NULL
O	NULL
:	NULL
Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
13:369	NULL
,	NULL
1995	NULL
20	NULL
.	NULL

Shuai	NULL
K	NULL
,	NULL
Horvath	NULL
CM	NULL
,	NULL
Huang	NULL
LH	NULL
,	NULL
Qureshi	NULL
SA	NULL
,	NULL
Cowburn	NULL
D	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Interferon	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Stat91	NULL
involves	NULL
dimerization	NULL
through	NULL
SH2-phosphotyrosyl	NULL
peptide	NULL
interac-tions	NULL
.	NULL

Cell	NULL
76:821	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Darnell	NULL
JE	NULL
Jr	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Stark	NULL
GR	NULL
:	NULL
Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
[	NULL
Review	NULL
]	NULL
.	NULL

Science	NULL
264:1415	NULL
,	NULL
1994	NULL
22	NULL
.	NULL

Thie	NULL
JN	NULL
:	NULL
STATs	NULL
:	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
84:331	NULL
,	NULL
1996	NULL
23	NULL
.	NULL

Nielsen	NULL
M	NULL
,	NULL
Svejgaard	NULL
A	NULL
,	NULL
Skov	NULL
S	NULL
,	NULL
Odum	NULL
N	NULL
:	NULL
Interleukin-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
stat3	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
12:3082	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Mu	NULL
SX	NULL
,	NULL
Xia	NULL
M	NULL
,	NULL
Elliot	NULL
G	NULL
,	NULL
Bogenberger	NULL
J	NULL
,	NULL
Swift	NULL
S	NULL
,	NULL
Bennett	NULL
L	NULL
,	NULL
Lappinga	NULL
DL	NULL
,	NULL
Hecht	NULL
R	NULL
,	NULL
Lee	NULL
R	NULL
,	NULL
Saris	NULL
CJ	NULL
:	NULL
Megakaryocyte	NULL
growth	NULL
and	NULL
development	NULL
factor	NULL
and	NULL
interleukin-3	NULL
induce	NULL
patterns	NULL
of	NULL
protein-tyrosine	NULL
phosphorylation	NULL
that	NULL
correlate	NULL
with	NULL
dominant	NULL
differentiation	NULL
over	NULL
proliferation	NULL
of	NULL
mpl-transfected	NULL
32D	NULL
cells	NULL
.	NULL

Blood	NULL
86:4532	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Caldenhoven	NULL
E	NULL
,	NULL
van	NULL
Dijk	NULL
T	NULL
,	NULL
Raaijmakers	NULL
JA	NULL
,	NULL
Lammers	NULL
JW	NULL
,	NULL
Koenderman	NULL
L	NULL
,	NULL
De	NULL
Groot	NULL
RP	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
STAT3/acute	NULL
phase	NULL
response	NULL
factor	NULL
transcription	NULL
factor	NULL
by	NULL
interleukin-5	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:25778	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Guschin	NULL
D	NULL
,	NULL
Rogers	NULL
N	NULL
,	NULL
Briscoe	NULL
J	NULL
,	NULL
Witthuhn	NULL
B	NULL
,	NULL
Watling	NULL
D	NULL
,	NULL
Hom	NULL
F	NULL
,	NULL
Pellegrini	NULL
S	NULL
,	NULL
Yasukawa	NULL
K	NULL
,	NULL
Heinrich	NULL
P	NULL
,	NULL
Stark	NULL
GR	NULL
,	NULL
Thle	NULL
JN	NULL
,	NULL
Kerr	NULL
IM	NULL
:	NULL
A	NULL
major	NULL
role	NULL
for	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
JAK	NULL
1	NULL
in	NULL
the	NULL
JAK/STAT	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
response	NULL
to	NULL
interleukin-6	NULL
.	NULL

EMBO	NULL
J	NULL
14:1421	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Yin	NULL
T	NULL
,	NULL
Keller	NULL
SR	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Tsang	NULL
ML	NULL
,	NULL
Lienhard	NULL
GE	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Yang	NULL
YC	NULL
:	NULL
Interleukin-9	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
insulin	NULL
receptor	NULL
substrate-1	NULL
via	NULL
JAK	NULL
tyrosine	NULL
kinases	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:20497	NULL
,	NULL
1995	NULL
28	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Winestock	NULL
KD	NULL
:	NULL
IL-10	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
tyk2	NULL
and	NULL
Jakl	NULL
and	NULL
the	NULL
differential	NULL
assembly	NULL
of	NULL
STAT1	NULL
alpha	NULL
and	NULL
STAT3	NULL
complexes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
155:1079	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Novak	NULL
U	NULL
,	NULL
Harpur	NULL
AG	NULL
,	NULL
Paradiso	NULL
L	NULL
,	NULL
Kanagasundaram	NULL
V	NULL
,	NULL
Ja-worowski	NULL
A	NULL
,	NULL
Wilks	NULL
AF	NULL
,	NULL
Hamilton	NULL
JA	NULL
:	NULL
Colony-stimulating	NULL
factor	NULL
1-induced	NULL
STAT1	NULL
and	NULL
STAT3	NULL
activation	NULL
is	NULL
accompanied	NULL
by	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
macrophages	NULL
and	NULL
Tyk2	NULL
and	NULL
JAK	NULL
1	NULL
in	NULL
fibroblasts	NULL
.	NULL

Blood	NULL
86:2948	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Zhong	NULL
Z	NULL
,	NULL
Wen	NULL
Z	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Stat3	NULL
:	NULL
A	NULL
STAT	NULL
family	NULL
member	NULL
activated	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
epidermal	NULL
growth	NULL
factor	NULL
and	NULL
interleukin-6	NULL
.	NULL

Science	NULL
264:95	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Leaman	NULL
DW	NULL
,	NULL
Pisharody	NULL
S	NULL
,	NULL
Flickinger	NULL
TW	NULL
,	NULL
Commane	NULL
MA	NULL
,	NULL
Schlessinger	NULL
J	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Levy	NULL
DE	NULL
,	NULL
Stark	NULL
GR	NULL
:	NULL
Roles	NULL
of	NULL
JAKs	NULL
in	NULL
activation	NULL
of	NULL
STATs	NULL
and	NULL
stimulation	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
by	NULL
epidermal	NULL
growth	NULL
factor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:369	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Ezumi	NULL
Y	NULL
,	NULL
Takayama	NULL
H	NULL
,	NULL
Okuma	NULL
M	NULL
:	NULL
Thrombopoietin	NULL
,	NULL
c-Mpl	NULL
ligand	NULL
,	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
,	NULL
JAK2	NULL
,	NULL
and	NULL
STAT3	NULL
,	NULL
3573	NULL
and	NULL
enhances	NULL
agonists-induced	NULL
aggregation	NULL
in	NULL
platelets	NULL
in	NULL
vitro	NULL
.	NULL

FEBS	NULL
Lett	NULL
374:48	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Geisler	NULL
C	NULL
,	NULL
Plesner	NULL
T	NULL
,	NULL
Pallesen	NULL
G	NULL
,	NULL
Skjigdt	NULL
K	NULL
,	NULL
Odum	NULL
N	NULL
,	NULL
Larsen	NULL
JK	NULL
:	NULL
Characterization	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
T3	NULL
complex	NULL
by	NULL
the	NULL
monoclonal	NULL
antibody	NULL
F101.01	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
27.685	NULL
,	NULL
1988	NULL
34	NULL
.	NULL

Odum	NULL
N	NULL
,	NULL
Martin	NULL
PJ	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Norris	NULL
NA	NULL
,	NULL
Grosmaire	NULL
LS	NULL
,	NULL
Hansen	NULL
JA	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Signal	NULL
transduction	NULL
by	NULL
HLA-DR	NULL
is	NULL
mediated	NULL
by	NULL
tyrosine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
and	NULL
regulated	NULL
by	NULL
CD45	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Hum	NULL
Immunol	NULL
32:85	NULL
,	NULL
1991	NULL
35	NULL
.	NULL

Busch	NULL
H	NULL
:	NULL
;	NULL
Isolation	NULL
and	NULL
purification	NULL
of	NULL
nuclei	NULL
.	NULL

Methods	NULL
Enzymol	NULL
12:417	NULL
,	NULL
1967	NULL
36	NULL
.	NULL

Caldenhoven	NULL
E	NULL
,	NULL
van	NULL
Dijk	NULL
TB	NULL
,	NULL
Solari	NULL
R	NULL
,	NULL
Armstrong	NULL
J	NULL
,	NULL
Raaijmakers	NULL
JAM	NULL
,	NULL
Lammers	NULL
JWJ	NULL
,	NULL
Koenderman	NULL
L	NULL
,	NULL
De	NULL
Groot	NULL
RP	NULL
:	NULL
STAT3beta	NULL
,	NULL
a	NULL
splice	NULL
variant	NULL
of	NULL
transcription	NULL
factor	NULL
STAT3	NULL
,	NULL
is	NULL
a	NULL
dominant	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:13221	NULL
,	NULL
1996	NULL
37	NULL
.	NULL

Knapp	NULL
W	NULL
:	NULL
Leucocyte	NULL
Typing	NULL
IV	NULL
.	NULL

White	NULL
Cell	NULL
Differentiation	NULL
Antigens	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
Oxford	NULL
,	NULL
1989	NULL
38	NULL
.	NULL

Nielsen	NULL
M	NULL
,	NULL
Svejgaard	NULL
A	NULL
,	NULL
Ropke	NULL
C	NULL
,	NULL
Nordahl	NULL
M	NULL
,	NULL
Odum	NULL
N	NULL
:	NULL
Staphylococcal	NULL
enterotoxins	NULL
modulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
expression	NULL
and	NULL
ligand-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Janus	NULL
protein-tyrosine	NULL
kinase	NULL
3	NULL
(	NULL
Jak3	NULL
)	NULL
and	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
proteins	NULL
)	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:10995	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Darzynkiewicz	NULL
Z	NULL
,	NULL
Bruno	NULL
S	NULL
,	NULL
Del	NULL
Bino	NULL
G	NULL
,	NULL
Gorezyca	NULL
W	NULL
,	NULL
Hotz	NULL
MA	NULL
,	NULL
Lassota	NULL
P	NULL
,	NULL
Traganos	NULL
F	NULL
:	NULL
Features	NULL
of	NULL
apoptotic	NULL
cells	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
[	NULL
Review	NULL
]	NULL
.	NULL

Cytometry	NULL
13:795	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Beadling	NULL
C	NULL
,	NULL
Guschin	NULL
D	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Ziemiecki	NULL
A	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Cantrell	NULL
DA	NULL
:	NULL
Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
STAT	NULL
proteins	NULL
by	NULL
interleukin-2	NULL
and	NULL
interferon	NULL
alpha	NULL
,	NULL
but	NULL
not	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
,	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
13:5605	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Nielsen	NULL
M	NULL
,	NULL
Odum	NULL
N	NULL
,	NULL
Bendtzen	NULL
K	NULL
,	NULL
Ryder	NULL
LP	NULL
,	NULL
Jakobsen	NULL
BK	NULL
,	NULL
Svejgaard	NULL
A	NULL
:	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
regulate	NULL
growth	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Exp	NULL
Clin	NULL
Immunogen	NULL
11:23	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Yamanaka	NULL
Y	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
signals	NULL
are	NULL
generated	NULL
through	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
gp130	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
Stat3	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
15:1557	NULL
,	NULL
1996	NULL
43	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Ichiba	NULL
M	NULL
,	NULL
Kiuchi	NULL
N	NULL
,	NULL
Kitaoka	NULL
T	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
A	NULL
central	NULL
role	NULL
for	NULL
Stat3	NULL
in	NULL
IL-6-induced	NULL
regulation	NULL
of	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
M1	NULL
leukemia	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
15:3651	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Claesson	NULL
MH	NULL
,	NULL
Dissing	NULL
S	NULL
,	NULL
Tscherning	NULL
T	NULL
,	NULL
Geisler	NULL
C	NULL
:	NULL
T-cell	NULL
activation	NULL
.	NULL

V.	NULL
Anti-major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
antibody-induced	NULL
activation	NULL
and	NULL
clonal	NULL
abortion	NULL
in	NULL
Jurkat	NULL
T-leukaemic	NULL
cells	NULL
.	NULL

Immunology	NULL
78:444	NULL
,	NULL
1993	NULL
45	NULL
.	NULL

Amirayan	NULL
N	NULL
,	NULL
Vernet	NULL
C	NULL
,	NULL
Machy	NULL
P	NULL
:	NULL
Class	NULL
I-specific	NULL
antibodies	NULL
inhibit	NULL
proliferation	NULL
in	NULL
primary	NULL
but	NULL
not	NULL
secondary	NULL
mouse	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

J	NULL
Immunol	NULL
148:1971	NULL
,	NULL
1992	NULL
46	NULL
.	NULL

Smith	NULL
DM	NULL
,	NULL
Bluestone	NULL
JA	NULL
,	NULL
Jeyarajah	NULL
DR	NULL
,	NULL
Newberg	NULL
MH	NULL
,	NULL
Engel-hard	NULL
VH	NULL
,	NULL
Thistlethwaite	NULL
JR	NULL
Jr	NULL
,	NULL
Woodle	NULL
ES	NULL
:	NULL
Inhibition	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
reactive	NULL
against	NULL
the	NULL
alpha	NULL
3	NULL
domain	NULL
of	NULL
human	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

J	NULL
Immunol	NULL
153:1054	NULL
,	NULL
1994	NULL
47	NULL
.	NULL

Wallen-Ohman	NULL
M	NULL
,	NULL
Borrebaeck	NULL
CA	NULL
:	NULL
A	NULL
cell	NULL
surface	NULL
antigen	NULL
(	NULL
BAL	NULL
)	NULL
defined	NULL
by	NULL
a	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
inducing	NULL
apoptosis	NULL
in	NULL
a	NULL
human	NULL
lymphocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
57:544	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1998	NULL
91	NULL
:	NULL
3566-3573	NULL
Activation	NULL
of	NULL
Stat-3	NULL
Is	NULL
Involved	NULL
in	NULL
the	NULL
Induction	NULL
of	NULL
Apoptosis	NULL
After	NULL
Ligation	NULL
of	NULL
Major	NULL
Histocompatibility	NULL
Complex	NULL
Class	NULL
I	NULL
Molecules	NULL
on	NULL
Human	NULL
Jurkat	NULL
T	NULL
Cells	NULL
Soren	NULL
Skov	NULL
,	NULL
Mette	NULL
Nielsen	NULL
,	NULL
Sgren	NULL
Bregenholt	NULL
,	NULL
Niels	NULL
Odum	NULL
and	NULL
Mogens	NULL
H.	NULL
Claesson	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
\se	NULL
@	NULL
.	NULL

/	NULL
{	NULL
Â®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/91/10/3566.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

